Phil Gold is a Canadian physician, scientist, professor and author.
The Canada Gairdner Wightman Award is annually awarded by the Gairdner Foundation to a Canadian who has demonstrated outstanding leadership in the field of medicine and medical science.
Henry George Friesen is a Canadian endocrinologist, a distinguished professor emeritus of the University of Manitoba and the discoverer of human prolactin, a hormone which stimulates lactation in mammary glands.
Connie Jean Eaves, CorrFRSE, is a Canadian biologist with significant contributions to cancer and stem cell research. Eaves is a professor generics of genetics at the University of British Columbia and is also the co-founder with Allen C Eaves of Terry Fox Laboratory.
Carol E. Cass is a Canadian research scientist. From 2003 to 2010, Cass served as director of Alberta's Cross Cancer Institute. She is Canada Research Chair in oncology at the University of Alberta and was elected a Fellow of the Royal Society of Canada and Canadian Academy of Health Sciences.
Janet Rossant, is a developmental biologist well known for her contributions to the understanding of the role of genes in embryo development. She is a world renowned leader in developmental biology. Her current research interests focus on stem cells, molecular genetics, and developmental biology. Specifically, she uses cellular and genetic manipulation techniques to study how genes control both normal and abnormal development of early mouse embryos. Rossant has discovered information on embryo development, how multiple types of stem cells are established, and the mechanisms by which genes control development. In 1998, her work helped lead to the discovery of the trophoblast stem cell, which has assisted in showing how congenital anomalies in the heart, blood vessels, and placenta can occur.
Professor David James Kerr CBE is a British Cancer Researcher. His primary area of research is treatment and management of colorectal cancer.
Alan Bernstein is Professor Emeritus at the University of Toronto and President Emeritus of CIFAR, where he served as President and CEO from 2012 to 2022. A Distinguished Fellow at the Munk School of Global Affairs and Public Policy, he is also a Fellow and Member of the Standing Committee for Science Planning at the International Science Council (2022-2025). Bernstein is recognized as a leader in health research, science policy, mentorship and organizational leadership.
Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member. Only four such awards have ever been conferred in the Faculty of Medicine. Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).
The UBC Faculty of Medicine is the medical school of the University of British Columbia. It is one of 17 medical schools in Canada and the only one in the province of British Columbia. It has Canada's largest undergraduate medical education program and the fifth-largest in the U.S. and Canada. It is ranked as the 2nd best medical program in Canada by Maclean's, and 27th in the world by the 2017 QS World University Rankings.
Lynne Elizabeth Maquat is an American biochemist and molecular biologist whose research focuses on the cellular mechanisms of human disease. She is an elected member of the American Academy of Arts and Sciences, the National Academy of Sciences and the National Academy of Medicine. She currently holds the J. Lowell Orbison Endowed Chair and is a professor of biochemistry and biophysics, pediatrics and of oncology at the University of Rochester Medical Center. Professor Maquat is also Founding Director of the Center for RNA Biology and Founding Chair of Graduate Women in Science at the University of Rochester.
Frances Alice Shepherd, is a Canadian oncologist recognized for her research on lung cancer and her contributions to the design, development, and conduct of clinical trials. She is currently a senior staff physician at Princess Margaret Cancer Centre, where she has held the Scott Taylor Chair in Lung Cancer Research since 2001, and she is a full professor in the Department of Medicine at the University of Toronto.
Kathleen I. Pritchard, is the head of oncology at Sunnybrook Health Sciences Centre in Toronto, Canada, specializing in breast cancer therapies, and leading the clinical trials division of the centre. She has authored numerous studies on women's health, breast cancer, hormone replacement therapy, public health, and research methodology. According to Thomson Reuters, Pritchard was one of the most cited researchers in the world in 2014 and 2015.
Nancy E. Davidson is the executive director and president of Seattle Cancer Care Alliance, senior vice president, director of clinical oncology at Fred Hutchinson Cancer Research Center and head of the Division of Medical Oncology at the University of Washington School of Medicine. She focuses her research on breast cancer treatments and the genes that are mutated in various forms of breast cancer. She was president of American Association for Cancer Research from 2015 to 2016 and president of American Society of Clinical Oncology from 2007 to 2008.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Georgina Venetia Long is Co-Medical Director of the Melanoma Institute Australia (MIA), and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney.
Deborah Watkins Bruner is an American researcher, clinical trialist, and academic. She is the senior vice president for research at Emory University. Her research focus is on patient reported outcomes, symptom management across cancer sites, sexuality after cancer treatment, and effectiveness of radiotherapy modalities. Bruner's research has been continually funding since 1998, with total funding of her research exceeding $180 million. She is ranked among the top five percent of all National Institutes of Health-funded investigators worldwide since 2012, according to the Blue Ridge Institute for Medical Research.
David Argyle BVMS DECVIM-CA (Oncology) FRSE FRSA FRCVS is Head of the College of Medicine and Veterinary Medicine at the University of Edinburgh.
Elizabeth Patton, Ph.D FRSE is professor of chemical genetics and group leader of Medical Research Council Institute for Genetics and Molecular Medicine (IGMM) Human Genetics Unit in Edinburgh, Personal Chair of Melanoma Genetics and Drug Discovery for a disease which kills 20,000 Europeans a year, and accounts for 80% of all skin cancer deaths. Her research into the genetic models and drug interactions testing, sharing international findings, is mainly using zebrafish in conjunction with the Edinburgh Cancer Research Centre. She holds a number of academic leadership roles in UK, Europe and international scientific bodies.
Gelareh Zadeh is an Iranian-Canadian neurosurgeon who is a professor and the Dan Family Chair in the Department of Surgery at the University of Toronto. She is a neurosurgeon-scientist at Toronto Western Hospital at University Health Network. In 2020, Zadeh became the first woman to be elected Chair of the Division of Neurosurgery at the University of Toronto. In 2023, she was one of the two winners of the inaugural Canada Gairdner Momentum Award.
